Further supporting this concept, our pan-cancer analysis of SOX15 gene expression showed it was recurrently downregulated in multiple cancer types with high frequencies of disruption (≥ 80%), including colon, stomach, prostate, and uterine cancers (Figure 3). The gene discussed is SOX15; the disease is cancer.